计算生物学市场规模、份额、增长分析、按应用、按最终用途、按服务、按地区 - 行业预测，2024-2031 年

2022年全球计算生物学市场规模估值为57亿美元，从2023年的67.5亿美元增长到2031年的262.6亿美元，预计在预测期内（2024-2031年）将增长。 18.5%。

由于药物发现研究和开发的增加、对预测模型的需求激增以及政府资助计划，计算生物学市场正在经历快速增长。这个跨学科领域利用理论概念和电脑模拟来详细探索生物系统，包括基因组学和药理学。值得注意的进步包括人类基因组计划，它展示了电脑在基因图谱方面的强大功能。百济神州和 Ambrx 等合作正在透过整合扩展遗传密码等创新平台来加强药物开发。为了因应临床试验中不断上升的成本和失败率，製药公司正在转向预测模型，市场预计将大幅扩张。公共和私营部门投资的增加继续增强了这个充满活力的部门。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境

计算生物学市场规模：依服务和复合年增长率（2024-2031）

• 市场概况
• 资料库
• 基础设施和硬体
• 软体平台

计算生物学市场规模：按应用和复合年增长率（2024-2031）

• 市场概况
• 药物发现与疾病建模
  • 目标识别
  • 目标检验
  • 先导化合物发现
  • 先导药物最适化
• 临床前药物开发
  • 药物动力学
  • 动态
• 临床试验
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段
• 计算基因组科学
• 计算蛋白质体学
• 其他的

计算生物学市场规模：依最终用途和复合年增长率（2024-2031）

• 市场概况
• 学术研究
• 製药业
• 产业

计算生物学市场规模与复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• DNAnexus, Inc.
• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Schrodinger, Inc.
• Compugen
• Aganitha AI Inc.
• Genedata AG
• QIAGEN
• Simulations Plus, Inc.
• Fios Genomics
• Certara
• Chemical Computing Group ULC
• Dassault Systemes
• Genedata AG
• Insilico Biotechnology AG

结论和建议

Global Computational Biology Market size was valued at USD 5.7 billion in 2022 and is poised to grow from USD 6.75 billion in 2023 to USD 26.26 billion by 2031, growing at a CAGR of 18.5% during the forecast period (2024-2031).

The computational biology market is experiencing rapid growth, driven by increasing drug discovery R&D, a surge in demand for predictive models, and government funding initiatives. Leveraging theoretical concepts and computer simulations, this multidisciplinary field enables detailed exploration of biological systems, including genomics and pharmacology. Notable advancements include the Human Genome Project, which showcased the power of computing in genetic mapping. Collaborations, such as that between BeiGene and Ambrx, are enhancing drug development by integrating innovative platforms like the Expanded Genetic Code. With pharmaceutical companies shifting towards predictive modeling in response to rising costs and failure rates in clinical trials, the market is poised for significant expansion. Increased investment from both public and private sectors continues to bolster this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computational Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computational Biology Market Segmental Analysis

Global Computational Biology Market is segmented by service, application, end-use and region. Based on service, the market is segmented into databases, infrastructure & hardware and software platform. Based on application, the market is segmented into drug discovery & disease modelling, preclinical drug development, clinical trial, computational genomics, computational proteomics and others. Based on end-use, the market is segmented into academic & research, pharmaceutical industry and industrial. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computational Biology Market

The global Computational Biology market is projected to witness significant growth driven by the increasing demand for advanced computational tools for genome sequencing. As more sophisticated software becomes accessible, scientists can efficiently conduct tasks such as creating PCR primers, identifying restriction enzyme cut sites, and converting DNA sequences into amino acids. The expanding databases and sequence analysis tools empower researchers to extract valuable insights regarding gene structures and functions, thereby enhancing the drug development process. By pinpointing functionally relevant protein sequences from extensive datasets, these computational approaches facilitate the discovery of new therapeutic targets and enable the engineering of synthetic DNA sequences, which further promotes innovation and commercialization in biotechnology. This rapid advancement in sequencing technology and analytical tools is expected to substantially boost market revenue in the coming years.

Restraints in the Global Computational Biology Market

The global computational biology market faces significant constraints primarily due to a scarcity of skilled professionals and a lack of standardized practices. Expertise in this field requires a strong foundation in programming, mathematics, and statistics, along with a comprehensive understanding of cloud computing and biological sciences. The interdisciplinary nature of computational biology often results in an absence of a cohesive curriculum, which may impede the ability of recent graduates to enhance their skill sets effectively. Furthermore, the field currently lacks established methods for addressing issues such as allergic reactions and post-surgical complications, potentially hindering market revenue growth in the future.

Market Trends of the Global Computational Biology Market

The global computational biology market is experiencing a robust upward trend, primarily fueled by the surge in clinical studies focused on pharmacogenomics, which enhances understanding of diverse patient populations' biological frameworks. This growing emphasis on personalized medicine, along with the need for rapid drug discovery and streamlined scientific research processes, is driving demand for computational biology solutions. Moreover, the increasing integration of computational tools across epigenomics, proteomics, and metagenomics sectors is pivotal in elucidating protein structures and interactions. Coupled with significant advancements in disease modeling and drug development, alongside heightened R&D investment from both private and public entities, the market is poised for sustained growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Computational Biology Market Size by Service & CAGR (2024-2031)

• Market Overview
• Databases
• Infrastructure & Hardware
• Software Platform

Global Computational Biology Market Size by Application & CAGR (2024-2031)

• Market Overview
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trial
  • Phase I
  • Phase Ii
  • Phase Iii
  • Phase Iv
• Computational Genomics
• Computational Proteomics
• Others

Global Computational Biology Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Academic & Research
• Pharmaceutical Industry
• Industrial

Global Computational Biology Market Size & CAGR (2024-2031)

• North America (Service, Application, End-Use)
  • USA
  • Canada
• Europe (Service, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• DNAnexus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Compugen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aganitha AI Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simulations Plus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fios Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chemical Computing Group ULC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genedata AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Biotechnology AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations